AlphaYouWB
Schedule 13G filing
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. disclosed a 6.1% stake in Korsana Biosciences, Inc. (KRSA)
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. reported owning 6.1% of Korsana Biosciences, Inc. (KRSA) (2,775,788 shares) in a Schedule 13G filed Sep 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 16, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.